Physician profile
Daniel E Stern
NPI 1639170889
$3,696.54
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $338 · 2020: $266 · 2021: $853 · 2022: $1,843 · 2023: $279 · 2024: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $381 · Travel and Lodging: $16.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $380.80 |
| Travel and Lodging | $16.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gotham Surgical Solutions & Devices, INC. | $1,216.95 | 2022 | |
| Paratek Pharmaceuticals, INC. | $778.15 | 2020-2024 | Nuzyra |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $284.63 | 2020-2024 | Jublia |
| Sandoz INC. | $249.10 | 2019-2021 | |
| Sebela Pharmaceuticals INC. | $218.54 | 2019-2022 | |
| Stryker Corporation | $206.55 | 2021 | |
| Alfasigma USA, INC. | $99.20 | 2021 | |
| Smith+Nephew, INC. | $80.64 | 2021-2022 | |
| Kerecis Limited | $74.58 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Treace Medical Concepts, INC. | $55.06 | 2022-2023 | |
| Integra Lifesciences Corporation | $47.91 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Zimmer Biomet Holdings, INC. | $39.26 | 2021 | |
| Advanced Oxygen Therapy INC. | $35.51 | 2022 | |
| Orthofix Medical, INC. | $34.43 | 2023 | Physio-Stim, Spinal-Stim |
| Wright Medical Technology, INC. | $33.28 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $30.38 | 2022 | |
| Grt US Holding, INC. | $22.63 | 2022 | |
| Boston Scientific Corporation | $21.86 | 2024 | |
| Mayne Pharma Commercial LLC | $21.42 | 2021 | |
| Novum Pharma, LLC | $21.37 | 2019 | |
| Molnlycke Health Care US, LLC | $20.50 | 2022 | |
| Medartis INC. | $19.70 | 2019 | |
| Mimedx Group, INC. | $19.35 | 2024 | |
| Bioventus LLC | $19.17 | 2023 | Exogen Ultrasound Bone Healing System |
| Musculoskeletal Transplant Foundation INC. | $16.40 | 2023 | |
| Reprise Biomedical, INC. | $15.51 | 2021 | |
| Acell, INC. | $14.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Stern listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.